Meta-Analysis Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Chronic Obstructive Pulmonary Disease

Am J Cardiol. 2022 Jul 1:174:188-189. doi: 10.1016/j.amjcard.2022.04.003. Epub 2022 May 9.
No abstract available

Publication types

  • Letter
  • Meta-Analysis

MeSH terms

  • Cardiovascular Diseases* / prevention & control
  • Diabetes Mellitus, Type 2*
  • Glucose
  • Humans
  • Hypoglycemic Agents
  • Pulmonary Disease, Chronic Obstructive* / drug therapy
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
  • Symporters*

Substances

  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors
  • Symporters
  • Sodium
  • Glucose